Results 21 to 30 of about 1,913 (212)

Anti‐CD20 therapy for multiple sclerosis‐associated uveitis: A case series

European Journal of Neurology, Volume 29, Issue 10, Page 3028-3038, October 2022., 2022
Approximately 1% of patients with multiple sclerosis (MS) have uveitis, but data on the effects of immunotherapies for MS on MS‐associated uveitis are scarce. In a retrospective study of 12 eyes of six patients with MS‐associated uveitis refractory to previous immunotherapies, we investigated the ophthalmological and neurological outcomes in patients ...
Frauke Stascheit, Anne Rübsam, Carolin Otto, Andreas Meisel, Klemens Ruprecht, Uwe Pleyer   +5 more
wiley   +1 more source

Emerging Theranostic Nanomaterials in Diabetes and Its Complications

Advanced Science, Volume 9, Issue 3, January 25, 2022., 2022
Nanomaterials have been widely used in various areas of medicine due to their mutable structures and extraordinary properties. This review paper comprehensively discusses the recent studies about the mechanisms and applications of functional nanomaterials in diabetes‐related diagnosis, prevention and therapy. Abstract Diabetes mellitus (DM) refers to a
Yuntao Liu, Siqi Zeng, Wei Ji, Huan Yao, Lin Lin, Haiying Cui, Hélder A. Santos, Guoqing Pan   +7 more
wiley   +1 more source

Cost‐effectiveness of dexamethasone and triamcinolone for the treatment of diabetic macular oedema in Finland: A Markov‐model

Acta Ophthalmologica, Volume 99, Issue 7, Page e1146-e1153, November 2021., 2021
Abstract Purpose Diabetic macular oedema (DMO), a complication of diabetes, causes vision loss and blindness. Corticosteroids are usually used as a second‐line treatment. The aim of this study was to analyse the cost‐effectiveness of dexamethasone implants compared to cheaper and more frequently applied triamcinolone injections.
Mari Pesonen, Eila Kankaanpää, Pasi Vottonen   +2 more
wiley   +1 more source

Role of Janus Kinase (JAK) Inhibitor in Autoimmune Ocular Inflammation: A Systematic Review

Journal of Immunology Research, Volume 2021, Issue 1, 2021., 2021
Purpose. To evaluate the effectiveness of Janus kinase (JAK) inhibitors for the treatment of patients with autoimmune disease and associated inflammatory ocular diseases. Methods. We identified relevant literature by screening the MEDLINE, PubMed, and Cochrane databases for randomized controlled trials, cohort studies, case controls, and case reports ...
Ji Wen, Huifang Hu, Menglin Chen, Hang Yang, Yi Zhao, Yi Liu, Chiara Posarelli   +6 more
wiley   +1 more source

Risk of Posterior Capsular Rupture during Phacoemulsification in Patients with the History of Anti‐VEGF Intravitreal Injections: Results from the Pan‐American Collaborative Retina Study (PACORES) Group

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Purpose. To assess the risk for capsular rupture during routine phacoemulsification in patients with a history of anti‐VEGF injections and other possible risk modifiers such as treatment patterns, type of anti‐VEGF agent, and experience of the surgeon, among others. Methods.
Raul Velez-Montoya, Idaira Sanchez-Santos, Mauricio Galvan-Chavez, Lihteh Wu, J. Fernando Arevalo, María H. Berrocal, Arturo A. Alezzandrini, Marta S. Figueroa, Roberto Gallego-Pinazo, Rosa Dolz-Marco, Clara Martinez-Rubio, Roberto Gonzalez-Salinas, Marco Pellegrini   +12 more
wiley   +1 more source

Preventing relapse in non-infectious uveitis affecting the posterior segment of the eye – evaluating the 0.2 μg/day fluocinolone acetonide intravitreal implant (ILUVIEN®)

Journal of Ophthalmic Inflammation and Infection, 2020
Background The current article is a short review of an Alimera Sciences-sponsored symposium held during The 15th International Ocular Inflammation Society Congress in Taiwan on the 14th November 2019 entitled, ‘Preventing relapse of non-infectious ...
Bahram Bodaghi, Quan Dong Nguyen, Glenn Jaffe, Ramin Khoramnia, Carlos Pavesio   +4 more
doaj   +1 more source

Intravitreal Therapy for Diabetic Macular Edema: An Update

Journal of Ophthalmology, Volume 2021, Issue 1, 2021., 2021
Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME represents a sight‐threatening condition, it is also among the most accessible to treatment. Many different treatment options including photocoagulation, intravitreal medical treatment (either vascular endothelial growth factor inhibitors or ...
Claudio Furino, Francesco Boscia, Michele Reibaldi, Giovanni Alessio, Enrique Mencía-Gutiérrez   +4 more
wiley   +1 more source

Corticosteroid implants for chronic non-infectious uveitis. [PDF]

, 2016
BACKGROUND: Uveitis is a term used to describe a heterogeneous group of intraocular inflammatory diseases of the anterior, intermediate, and posterior uveal tract (iris, ciliary body, choroid).
Brady, Christopher J, Garg, Sunir J., Law, Hua Andrew, Rahimy, Ehsan, Reddy, Rahul, Sieving, Pamela C., Tang, Johnny, Villanti, Andrea C   +7 more
core   +2 more sources

Anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule

American Journal of Ophthalmology Case Reports, 2020
Purpose: To describe a case of spontaneous anterior migration of intravitreal fluocinolone acetonide (Iluvien®) implant in a pseudophakic eye with intact posterior capsule.
Manal Alzaabi, Abdel Hakim Taguri, Ahmed Elbarky   +2 more
doaj   +1 more source

Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis

Frontiers in Pharmacology, 2022
Background: To compare the efficacy and safety of advanced intravitreal therapeutic regimens, including a dexamethasone implant at 350 and 700 μg; a fluocinolone acetonide (FA) implant, 0.2 µg/day, 0.59 and 2.1 mg; intravitreal bevacizumab, 1.25 mg ...
Weiting Liao, Zhenyu Zhong, Guannan Su, Xiaojie Feng, Peizeng Yang   +4 more
doaj   +1 more source